1. Home
  2. INMD vs DLY Comparison

INMD vs DLY Comparison

Compare INMD & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INMD
  • DLY
  • Stock Information
  • Founded
  • INMD 2008
  • DLY 2019
  • Country
  • INMD Israel
  • DLY United States
  • Employees
  • INMD N/A
  • DLY N/A
  • Industry
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DLY Investment Managers
  • Sector
  • INMD Health Care
  • DLY Finance
  • Exchange
  • INMD Nasdaq
  • DLY Nasdaq
  • Market Cap
  • INMD 887.0M
  • DLY 759.6M
  • IPO Year
  • INMD 2019
  • DLY N/A
  • Fundamental
  • Price
  • INMD $14.30
  • DLY $15.58
  • Analyst Decision
  • INMD Hold
  • DLY
  • Analyst Count
  • INMD 6
  • DLY 0
  • Target Price
  • INMD $17.56
  • DLY N/A
  • AVG Volume (30 Days)
  • INMD 1.8M
  • DLY 215.9K
  • Earning Date
  • INMD 07-31-2025
  • DLY 01-01-0001
  • Dividend Yield
  • INMD N/A
  • DLY 8.93%
  • EPS Growth
  • INMD 8.69
  • DLY N/A
  • EPS
  • INMD 2.29
  • DLY N/A
  • Revenue
  • INMD $392,408,000.00
  • DLY N/A
  • Revenue This Year
  • INMD $0.16
  • DLY N/A
  • Revenue Next Year
  • INMD $4.84
  • DLY N/A
  • P/E Ratio
  • INMD $6.28
  • DLY N/A
  • Revenue Growth
  • INMD N/A
  • DLY N/A
  • 52 Week Low
  • INMD $13.14
  • DLY $13.26
  • 52 Week High
  • INMD $19.85
  • DLY $15.95
  • Technical
  • Relative Strength Index (RSI)
  • INMD 48.92
  • DLY 52.66
  • Support Level
  • INMD $13.14
  • DLY $15.43
  • Resistance Level
  • INMD $14.32
  • DLY $15.65
  • Average True Range (ATR)
  • INMD 0.40
  • DLY 0.11
  • MACD
  • INMD 0.05
  • DLY -0.01
  • Stochastic Oscillator
  • INMD 58.49
  • DLY 39.70

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

Share on Social Networks: